A federal judge in New York has frozen the assets of dozens of people and entities accused of operating a massive nationwide scheme to distribute counterfeit bottles of Gilead Sciences Inc. HIV drugs, including two alleged “kingpins.”
https://www.pharmalive.com/wp-content/uploads/2021/05/Russian-court-rejects-U.S-firms-lawsuit-over-COVID-19-drug-remdesivir-Reuters-5-27-21.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-09-28 21:05:292022-09-29 09:49:50Gilead widens battle against alleged counterfeit HIV drug ring